Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgo Blockchai. Regulatory News (ARB)

  • There is currently no data for ARB

Holding(s) in Company

5 Jul 2019 17:14

RNS Number : 7050E
Argo Blockchain PLC
05 July 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Argo Blockchain PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Hadron Capital LLP

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

04/07/19

6. Date on which issuer notified (DD/MM/YYYY):

05/07/19

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.95%

 

6.95%

20,423,000

Position of previous notification (if

applicable)

7.55%

 

7.55%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

GB00BZ15CS02

20,423,000

 

6.95%

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

20,423,000

6.95%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

London, UK

Date of completion

05/07/19

 

 

 

Notes

 

i Please note that national forms may vary due to specific national legislation (Article 3(1a) of Directive 2004/109/EC) as for instance the applicable thresholds or information regarding capital holdings.

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h)/ Article 10 (b) to (h) of Directive 2004/109/EC; (c) all parties to the agreement referred to in Article 10 (a) of Directive 2004/109/EC (DTR5.2.1 (a)) or (d) the holder of financial instruments referred to in Article 13(1) of Directive 2004/109/EC (DTR5.3.1).

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in points (b) to (h) of Article 10 of Directive 2004/109/EC (DTR5.2.1 (b) to (h)), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in letter (b) of Article 10 of that Directive (DTR5.2.1 (b)), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in letter (c) of Article 10 of that Directive (DTR5.2.1 (c)), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in letter (d) of Article 10 of that Directive (DTR5.2.1 (d)), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in letter (e) of Article 10 of that Directive (DTR5.2.1 (e)), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 9 (DTR 5.1), under letters (a) to (d) of Article 10 of that Directive (DTR5.2.1 (a) to (d)) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in letter (f) of Article 10 of that Directive (DTR5.2.1 (f)), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in letter (g) of Article 10 of that Directive (DTR5.2.1 (g)), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in letter (h) of Article 10 of that Directive (DTR5.2.1 (h)), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC (DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in Article 10 of that Directive (DTR5.2) unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold in accordance with national law, please note that it might not be necessary in accordance with national law to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (Article 13(1a) of Directive 2004/109/EC) (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only thus the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.).

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLRAMFTMBBMBBL
Date   Source Headline
10th Dec 20256:01 pmRNSCourt agrees to sanction Restructuring Plan
10th Dec 20254:26 pmRNSBond Redemption and Exchange
8th Dec 20256:20 pmRNSCourt sanction hearing update
3rd Dec 20253:31 pmRNSResults of Meetings
27th Nov 20257:00 amRNSSupplementary Explanatory Statement
24th Nov 20257:00 amRNSADS Ratio Change Effective Date
21st Nov 20257:00 amRNSConversion to ADS / Timetable / Town Hall Video
13th Nov 20257:00 amRNSRestructuring Plan – Town Hall Meeting / Timetable
7th Nov 20257:00 amRNSConvening Hearing Results and Notice of GM
31st Oct 20255:00 pmRNSUpdate on Restructuring Plan Process
30th Oct 20255:38 pmRNSFiling of Restructuring Plan Claim Form
21st Oct 20257:00 amRNSRestructuring Plan & LSE Delisting Update
30th Sep 20257:00 amRNSArgo 2025 Interim Results
22nd Sep 20257:00 amRNSAppointment of CFO and Nasdaq Listing Update
12th Sep 20257:00 amRNSManagement Change and TVR Update
10th Sep 20257:00 amRNSEntry into Amended RSA and Loan Agreement
22nd Aug 20257:00 amRNSUpdate to Proposed Recapitalization
11th Aug 20257:00 amRNSDirectorate Change
24th Jul 20257:00 amRNSNasdaq Delisting Notice and Hearing Request
15th Jul 20257:00 amRNSTR-1 Standard Notification of Major Holdings
11th Jul 20257:00 amRNSTR-1 Standard Notification of Major Holdings
8th Jul 20257:00 amRNSTR-1 Standard Notification of Major Holdings
7th Jul 20257:00 amRNSTR-1 Standard Notification of Major Holdings
1st Jul 20255:26 pmRNSResults of Adjourned Annual General Meeting
1st Jul 20259:10 amRNSInformation regarding Growler
30th Jun 20256:10 pmRNSAdjournment of AGM
30th Jun 20257:45 amRNSRestructuring and Directorate Change
5th Jun 20257:00 amRNSNotice of AGM
9th May 20257:00 amRNS2024 Annual Results and Restoration of Listing
30th Apr 20258:25 amRNSFinancial Update and Listing Suspension Request
30th Apr 20257:00 amRNSFinancial Update and Listing Suspension Request
14th Apr 20257:00 amRNSArgo Provides Financing Update
26th Mar 20257:00 amRNSArgo Enters into Term Sheets with Gem Mining
24th Mar 20257:04 amRNSAppointment of Chief Executive Officer
20th Mar 20257:00 amRNSHosting Update
17th Mar 20253:29 pmRNSArgo Provides an Update on Financing Discussions
17th Mar 202512:05 pmRNSTerm Sheet Cancellation
3rd Mar 20257:00 amRNSTerm Sheet for up to $40 Million Financing
24th Feb 20257:00 amRNSHosting Update
14th Feb 20257:00 amRNSBlock listing Interim Review
3rd Feb 20257:00 amRNSPDMR Dealing
27th Jan 20257:00 amRNSArgo Company Update - Hosting
21st Jan 20257:00 amRNSArgo CEO Change
17th Jan 20257:00 amRNSCompany Update Notification Re Minimum Bid Price
7th Jan 20257:00 amRNSDecember Operational Update
4th Dec 20247:00 amRNSArgo November Ops Update
2nd Dec 20247:00 amRNS£4.2 million Subscription by Institution
29th Nov 20247:00 amRNSVesting of PSU Award PDMR Dealing
20th Nov 20247:00 amRNSArgo 3rd Quarter Results
14th Nov 20247:00 amRNSNotice of Q3 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.